Periscope Capital Inc. Has $3.42 Million Holdings in Oaktree Acquisition Corp. III Life Sciences $OACC

Periscope Capital Inc. lessened its stake in Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) by 19.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 323,400 shares of the company’s stock after selling 76,600 shares during the quarter. Periscope Capital Inc. owned approximately 1.44% of Oaktree Acquisition Corp. III Life Sciences worth $3,422,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in OACC. Millennium Management LLC acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 1st quarter valued at approximately $4,848,000. Goldman Sachs Group Inc. acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 1st quarter valued at approximately $5,417,000. JPMorgan Chase & Co. acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 2nd quarter valued at approximately $2,094,000. Whitebox Advisors LLC acquired a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 2nd quarter valued at approximately $2,612,000. Finally, Lighthouse Investment Partners LLC boosted its holdings in shares of Oaktree Acquisition Corp. III Life Sciences by 88.9% in the 2nd quarter. Lighthouse Investment Partners LLC now owns 850,000 shares of the company’s stock valued at $8,882,000 after buying an additional 400,000 shares during the last quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Oaktree Acquisition Corp. III Life Sciences in a report on Thursday, April 2nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has an average rating of “Sell”.

Oaktree Acquisition Corp. III Life Sciences Price Performance

Shares of Oaktree Acquisition Corp. III Life Sciences stock opened at $10.68 on Friday. The business has a fifty day simple moving average of $10.66 and a two-hundred day simple moving average of $10.64. Oaktree Acquisition Corp. III Life Sciences has a 1 year low of $10.30 and a 1 year high of $10.74.

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) last announced its quarterly earnings results on Thursday, March 26th. The company reported $0.08 earnings per share (EPS) for the quarter.

About Oaktree Acquisition Corp. III Life Sciences

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.